Access to antibiotics: not a problem in some LMICs

  19 March 2021

Poor access to antibiotics is estimated to cause substantial morbidity and mortality due to pneumonia and acute febrile illness among children younger than 5 years, with most of these events happening in low-income and middle-income countries (LMICs). However, a study set in eight LMICs showed that children received around 25 antibiotic prescriptions for respiratory tract infection or fever during their first 5 years of life, and most of these prescriptions were deemed inappropriate. This conflicting finding calls for better understanding of issues surrounding antibiotic access and use in LMICs, because these countries simultaneously face high burdens of antimicrobial resistance.

Further reading: The Lancet Global Health
Author(s): Giorgia Sulis, Sumanth Gandra
Effective Surveillance   Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed